Terms: = Uterine cancer AND ER, estrogen receptor AND Staging
38 results:
1. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
2. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
3. PET Imaging of estrogen receptors for Gynecological Tumors.
Tsujikawa T; Makino A; Mori T; Tsuyoshi H; Kiyono Y; Yoshida Y; Okazawa H
Clin Nucl Med; 2022 Jul; 47(7):e481-e488. PubMed ID: 35675139
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract] [Full Text] [Related]
5. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract] [Full Text] [Related]
7. [Microcystic, elongated and fragmented invasive pattern in endometrial adenocarcinoma: a clinicopathologic analysis of 72 cases].
Hu D; Zhang HJ; Shen WC; Zhu WF; Li L; Lin XD; Lu JP; Zheng XW; Wang C; Zhou XR
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):318-322. PubMed ID: 28468037
[No Abstract] [Full Text] [Related]
8. Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C; Stepan AE; MehedinŢu C; Cîrstoiu MM; Ciortea R; Berceanu S; Gheonea IA; Brătilă E
Rom J Morphol Embryol; 2016; 57(3):995-1002. PubMed ID: 28002515
[TBL] [Abstract] [Full Text] [Related]
9. Expression of Ezrin and estrogen receptors During Cervical Carcinogenesis.
Fadiel A; Choi SD; Park B; Kim TH; Buldo-Licciardi J; Ahmadi M; Arslan A; Mittal K; Naftolin F
Reprod Sci; 2017 May; 24(5):706-712. PubMed ID: 27688241
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
[TBL] [Abstract] [Full Text] [Related]
11. Tumor Characteristics and Survival Outcome of Endometrial cancer Arising in Adenomyosis: An Exploratory Analysis.
Matsuo K; Moeini A; Machida H; Scannell CA; Casabar JK; Kakuda M; Adachi S; Garcia-Sayre J; Ueda Y; Roman LD
Ann Surg Oncol; 2016 Mar; 23(3):959-67. PubMed ID: 26542589
[TBL] [Abstract] [Full Text] [Related]
12. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract] [Full Text] [Related]
13. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.
Visser NC; Bulten J; van der Wurff AA; Boss EA; Bronkhorst CM; Feijen HW; Haartsen JE; van Herk HA; de Kievit IM; Klinkhamer PJ; Pijlman BM; Snijders MP; Vandenput I; Vos MC; de Wit PE; van de Poll-Franse LV; Massuger LF; Pijnenborg JM
BMC Cancer; 2015 Jun; 15():487. PubMed ID: 26123742
[TBL] [Abstract] [Full Text] [Related]
14. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical staging of Pelvic cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract] [Full Text] [Related]
15. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical significance of FIGO 2009 staging I and its prognostic related factors in endometrial carcinoma].
Zhou J; Zhao L; Qi W; Li X; Wang J; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):776-9. PubMed ID: 25537252
[TBL] [Abstract] [Full Text] [Related]
17. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract] [Full Text] [Related]
18. Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
Li M; Zhao L; Shen D; Li X; Wang J; Wei L
Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases.
Yoon A; Park JY; Park JY; Lee YY; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW; Nam JH
Gynecol Oncol; 2014 Jan; 132(1):70-5. PubMed ID: 24184602
[TBL] [Abstract] [Full Text] [Related]
20. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.
Zhang Y; Garcia-Buitrago MT; Koru-Sengul T; Schuman S; Ganjei-Azar P
Int J Gynecol Pathol; 2013 Sep; 32(5):476-81. PubMed ID: 23896709
[TBL] [Abstract] [Full Text] [Related]
[Next]
